Recommendations for the successful identification of altered human remains using standard and emerging technologies: Results of a systematic approach.


Journal

Forensic science international. Genetics
ISSN: 1878-0326
Titre abrégé: Forensic Sci Int Genet
Pays: Netherlands
ID NLM: 101317016

Informations de publication

Date de publication:
01 2023
Historique:
received: 29 04 2022
revised: 07 10 2022
accepted: 10 10 2022
pubmed: 23 10 2022
medline: 15 12 2022
entrez: 22 10 2022
Statut: ppublish

Résumé

Successful DNA-based identification of altered human remains relies on the condition of the corpses and varies between tissue types. Therefore, the aim of this prospective multicenter study was to generate evidence-based recommendations for the successful identification of altered remains. For this, 19 commonly used soft and hard tissues from 102 altered human bodies were investigated. The corpses' condition was categorized into three anatomical regions using a practical scoring system. Besides other data, DNA yields, degradation indices, and short tandem repeat (STR) profile completeness were determined in 949 tissue samples. Additionally, varying degrees of alteration and tissue-specific differences were evaluated using the Next Generation Sequencing (NGS) platform MiSeq FGx™. Selected challenging samples were sequenced in parallel with the Ion S5™ platform to assess platform-specific performances in the prediction of the deceased's phenotype and the biogeographic ancestry. Differences between tissue types and DNA extraction methods were found, revealing, for example, the lowest degradation for vertebral disc samples from corpses with initiating, advanced and high degrees of decomposition. With respect to STR profile completeness, blood samples outperformed all other tissues including even profoundly degraded corpses. NGS results revealed higher profile completeness compared to standard capillary electrophoresis (CE) genotyping. Per sample, material and degradation degree, a probability for its genotyping success, including the "extended" European Standard Set (eESS) loci, was provided for the forensic community. Based on the observations, recommendations for the alteration-specific optimal tissue types were made to improve the first-attempt identification success of altered human remains for forensic casework.

Identifiants

pubmed: 36272213
pii: S1872-4973(22)00131-4
doi: 10.1016/j.fsigen.2022.102790
pii:
doi:

Substances chimiques

DNA 9007-49-2

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102790

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interests The authors declare they have no conflict of interest.

Auteurs

Alina Senst (A)

Institute of Forensic Medicine, University Basel, Pestalozzistrasse 22, 4056 Basel, Switzerland.

Amke Caliebe (A)

Institute of Medical Informatics and Statistics, Kiel University and University-Hospital Schleswig-Holstein, Brunswiker Str. 10, 24105 Kiel, Germany.

Matthias Drum (M)

Institute of Forensic Medicine, Kantonsspital St. Gallen, Rorschacher Strasse 95, 9007 St. Gallen, Switzerland.

Christian Cossu (C)

Institute of Forensic Medicine, Kantonsspital St. Gallen, Rorschacher Strasse 95, 9007 St. Gallen, Switzerland.

Martin Zieger (M)

Institute of Forensic Medicine, University Bern, Murtenstrasse 26, 3008 Bern, Switzerland.

Eva Scheurer (E)

Institute of Forensic Medicine, University Basel, Pestalozzistrasse 22, 4056 Basel, Switzerland.

Iris Schulz (I)

Institute of Forensic Medicine, University Basel, Pestalozzistrasse 22, 4056 Basel, Switzerland. Electronic address: Iris.schulz@bs.ch.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH